| Ytd | 116.55% | |
| 1y | 132.77% |
| Open | 21.03 | Prev Close | 21.03 | Low | 20.59 | High | 21.05 | Mkt Cap | 278.50M |
| Vol | 118.47K | Avg Vol | 95.72K | EPS | -0.23 | P/E | N/A | Forward P/E | -81.65 |
| Beta | 0.86 | Short Ratio | 2.43 | Inst. Own | 91.59% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-04 | 50-d Avg | 19.26 | 200-d Avg | 14.39 | 1yr Est | 26.50 |
B. Riley Securities analyst Madison El-Saadi assumes Anika Therapeutics (NASDAQ:ANIK) with a Buy
Anika Therapeutics (NASDAQ: ANIK - Get Free Report) and Xencor (NASDAQ: XNCR - Get Free Report) are
Corient Private Wealth LP bought a new stake in shares of Anika Therapeutics Inc. (NASDAQ: ANIK) dur
Hsbc Holdings PLC purchased a new position in shares of Anika Therapeutics Inc. (NASDAQ: ANIK) durin
BTSG, ANIK and OPHC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 26th, 2
Anika (ANIK) could be a solid choice for shorter-term investors looking to capitalize on the recent
ANIK's strong sales momentum and raised 2026 guidance bolster investor confidence, while Cingal and
Five stocks, including EDRY, OPHC, FET, ANIK and NESR, show strong recent price gains and earnings g
Does Anika Therapeutics (ANIK) have what it takes to be a top stock pick for momentum investors? Let
Five stocks, including OPHC, EDRY, ENVA, ANIK and GEO, show strong recent price gains and earnings g
Anika (ANIK) could be a solid choice for shorter-term investors looking to capitalize on the recent
B. Riley Securities analyst Anderson Schock maintains Anika Therapeutics (NASDAQ:ANIK) with a Buy
Anika Therapeutics, Inc. (ANIK) Q2 2026 Earnings Call Transcript
Anika Therapeutics NASDAQ: ANIK reported higher second-quarter revenue, expanded gross margin and it
Gainers Autonomix Medical (NASDAQ:AMIX) shares moved upwards by 62.5% to $4.47 during Wednesday'
Anika Therapeutics (NASDAQ:ANIK) raises FY2026 sales outlook from $114.000 million-$122.500 million
BEDFORD, Mass., July 15, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global
BEDFORD, Mass., June 05, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global
Anika Therapeutics is refocusing on HA-based OA pain management and regenerative orthopedic products
Anika Therapeutics, Inc. (ANIK) Q1 2026 Earnings Call Transcript
Anika Therapeutics (NASDAQ:ANIK) affirms FY2026 sales outlook from $114.000 million-$122.500 million
Anika Therapeutics (NASDAQ:ANIK) reported quarterly earnings of $0.27 per share which beat the analy
Grew total company revenue 13%, driven by Commercial Channel strength and favorable OEM Channel orde
BEDFORD, Mass., April 15, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global
On April 10, 2026, Anika Therapeutics Inc (ANIK) shares fell 3.1% to a current price of $14.76. This
BEDFORD, Mass., April 03, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global
2 stocks in healthcare sector flashing warning to investors who value momentum. RSI is an indicator
Fiscal 2026 GuidanceAnika is providing the following 2026 guidance:Total Company Revenue between $11
Anika Therapeutics (NASDAQ:ANIK) reported quarterly earnings of $0.31 per share which beat the analy
Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarte
Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly ear
On Tuesday, 164 companies achieved new lows for the year.
On Thursday, 128 companies set new 52-week lows.
On Wednesday, 155 companies set new 52-week lows.
During Tuesday's trading, 188 companies set new 52-week lows.
Companies Reporting Before The Bell • Warner Music Gr (NASDAQ:WMG) is likely to report quarterly ea
On Monday, 149 companies reached new 52-week lows.